HKTDC International Sourcing Show Opens on 17 March, Online-and-Offline Fair Helps Businesses Capture New Opportunities
17.3.2021 04:44:00 EET | Business Wire | Press release
The Hong Kong Trade Development Council (HKTDC) is debuting the HKTDC International Sourcing Show, a trade exhibition held in both online and physical formats, to help businesses adjust to the new sourcing model. The online section of the show begins on 17 March and will enable buyers and suppliers to engage through business matching and video conferencing tools. Once the pandemic situation eases, businesses can join the physical show at the Hong Kong Convention and Exhibition Centre from 26 to 29 July to explore further opportunities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316006131/en/
In response to the pandemic’s impact on trade exhibitions globally, the HKTDC is debuting the HKTDC International Sourcing Show that will be held in both online and physical formats. The online section of the show begins on 17 March. At an online media briefing held on 16 March to introduce the event, HKTDC Deputy Executive Director Benjamin Chau gave an overview of the show’s highlights (Photo: Business Wire)
With the theme “Your Source of Inspiration”, the show will highlight a broad range of quality lifestyle products and solutions:
- Smart Home: Featuring an extensive selection of houseware, home textiles and furnishings
- Smart Play: Showcasing a range of baby products and toys and games
- Smart Style: Highlighting fashion products, gifts and premiums as well as printing and packaging solutions
- Smart Tech: Displaying electronics, lighting and medical and healthcare products employing the latest technologies.
More than 1,400 companies from 20 countries and regions will exhibit at the show. Some exhibitors have opted to use 3D virtual booths to promote their brands and products in more eye-catching ways. The HKTDC has also launched a product video production service to enable resource-strapped SMEs to design and produce videos to help them catch the attention of buyers.
Over 60 industry luminaries are invited to share their insights in 17 webinars. Highlighted webinars include “International Sourcing Outlook”, “Survive and Thrive: Leveraging End-to-end E-commerce Solutions” and “Utilising Licensing to Expand Your Business”.
Highlighted speakers include Devin Dai, Director of Category Management at Alibaba.com, Shinya Hisanaga, Director of Buying and Logistics at AEON Stores (Hong Kong), Flavien Serra, Founder of DTL Sourcing, Fione Tan, Co-founder of 28Mall.com, and Benson Ng, Hong Kong Business Consulting Leader at EY.
Furthermore, the show will continue to feature Click2Match, an AI-powered online business matching platform. Buyers and suppliers can use the tool to enjoy functions such as a meeting planner, video meetings, live chat and e-business card exchange, helping them to overcome barriers under the pandemic and build business connections around the world.
Don’t miss this chance to get inspired. Register now to source, learn, connect and explore.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316006131/en/
Contact information
Hong Kong Trade Development Council
Cathy Li cathy.hm.li@hktdc.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom